European Investor
28 Jul 2026, 09:26
Brown & Brown Stock Falls 2% in Premarket as Weak Organic Growth Overshadows Strong Revenue Gains
Brown & Brown (NYSE: BRO) shares slipped about 2% in premarket trading after the insurance brokerage reported strong headline revenue growth but disappointed investors with weaker-than-expected organic growth.
Second-quarter revenue rose 30.4% year over year to $1.7 billion, driven primarily by acquisitions and continued expansion across the business. Net income increased 24.7% to $288 million, while diluted earnings per share rose 7.7% to $0.84. Adjusted diluted EPS also increased 3.9% to $1.07.
Despite the strong headline results, investors focused on the company's underlying growth trends. Organic revenue declined 0.7% during the quarter, although organic revenue including contingent commissions increased a modest 0.7%. The weak organic performance suggests that most of Brown & Brown's growth continues to come from acquisitions rather than its existing operations.
Profitability also softened slightly. Income before taxes margin declined to 22.9% from 24.2% a year earlier, while adjusted EBITDAC margin eased to 35.7% from 36.7%, indicating modest margin pressure despite the significant increase in total revenue.
The first-half results painted a similar picture. Revenue increased 33.0% to $3.6 billion, while adjusted EPS rose 6.0%. However, organic revenue declined 0.3%, or increased only 1.6% when contingent commissions were included, reinforcing concerns about slowing underlying business momentum.
The market's negative reaction appears to reflect those concerns. While Brown & Brown continues to deliver strong acquisition-driven growth and solid earnings, investors typically place significant emphasis on organic revenue growth as a measure of the health of an insurance broker's core business. The decline in reported organic revenue and slight margin compression likely outweighed the otherwise strong financial performance, contributing to today's premarket pullback.
Brown & Brown (NYSE: BRO) shares slipped about 2% in premarket trading after the insurance brokerage reported strong headline revenue growth but disappointed investors with weaker-than-expected organic growth.
Second-quarter revenue rose 30.4% year over year to $1.7 billion, driven primarily by acquisitions and continued expansion across the business. Net income increased 24.7% to $288 million, while diluted earnings per share rose 7.7% to $0.84. Adjusted diluted EPS also increased 3.9% to $1.07.
Despite the strong headline results, investors focused on the company's underlying growth trends. Organic revenue declined 0.7% during the quarter, although organic revenue including contingent commissions increased a modest 0.7%. The weak organic performance suggests that most of Brown & Brown's growth continues to come from acquisitions rather than its existing operations.
Profitability also softened slightly. Income before taxes margin declined to 22.9% from 24.2% a year earlier, while adjusted EBITDAC margin eased to 35.7% from 36.7%, indicating modest margin pressure despite the significant increase in total revenue.
The first-half results painted a similar picture. Revenue increased 33.0% to $3.6 billion, while adjusted EPS rose 6.0%. However, organic revenue declined 0.3%, or increased only 1.6% when contingent commissions were included, reinforcing concerns about slowing underlying business momentum.
The market's negative reaction appears to reflect those concerns. While Brown & Brown continues to deliver strong acquisition-driven growth and solid earnings, investors typically place significant emphasis on organic revenue growth as a measure of the health of an insurance broker's core business. The decline in reported organic revenue and slight margin compression likely outweighed the otherwise strong financial performance, contributing to today's premarket pullback.
